Table 1 Expression of Plexin-B1 in ovarian tissues of different pathological changes and its correlation with clinical characteristics
From: Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion
| Â | Â | Plexin-B1 expression | Â | Â | |
|---|---|---|---|---|---|
N = 120 | Cases | Positive | Negative | Positive Percentage (%) | P |
Normal & Benign | 20 | 3 | 17 | 15.00 | <0.001* n.s.** |
Borderline | 20 | 7 | 13 | 35.00 | n.s.* |
Carcinoma | 80 | 44 | 36 | 55.00 | Â |
Nodal status | Â | Â | Â | Â | Â |
   Positive | 28 | 21 | 7 | 75.00 | 0.008 |
   Negative | 52 | 23 | 29 | 44.23 |  |
Tumour stage | Â | Â | Â | Â | Â |
   I | 20 | 9 | 11 | 45.00 | n.s. |
   II | 20 | 10 | 10 | 50.00 |  |
   III | 20 | 11 | 9 | 55.00 |  |
   IV | 20 | 14 | 6 | 70.00 |  |
Age(y) | Â | Â | Â | Â | Â |
   <40 | 32 | 18 | 14 | 56.25 | n.s. |
   ≥40 | 48 | 26 | 22 | 54.17 |  |
Cell differentiation | Â | Â | Â | Â | Â |
   High | 32 | 14 | 18 | 43.75 | n.s. |
   Medium | 30 | 18 | 12 | 60.00 |  |
   Low | 18 | 12 | 6 | 66.67 |  |